• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氟喹诺酮类药物利用与耐药模式:来自发展中国家的三级医院回顾性横断面分析研究。

Patterns of fluoroquinolone utilization and resistance in a tertiary care hospital: a retrospective cross-sectional analysis study from a developing country.

机构信息

Infection Control Department, An-Najah National University Hospital, Nablus, 44839, Palestine.

Department of Clinical and Community Pharmacy, College of Medicine and Health Sciences, An-Najah National University, Nablus, 44839, Palestine.

出版信息

BMC Infect Dis. 2024 Aug 23;24(1):856. doi: 10.1186/s12879-024-09749-4.

DOI:10.1186/s12879-024-09749-4
PMID:39179971
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11342551/
Abstract

BACKGROUND

Fluoroquinolones are the most commonly prescribed antibiotics. Because of their known tendency to drive antimicrobial resistance, their prescribing patterns need to be more restricted. This study aimed to describe the clinical practice of fluoroquinolone prescription, dose adjustments for renal impairment patients and bacterial resistance profiles, eventually providing evidence-based recommendations to optimize antibiotic prescribing practices in the local population.

METHODS

This retrospective, cross-sectional study was conducted at An-Najah National University Hospital in Palestine. The data were collected from admitted patients who were given ciprofloxacin or levofloxacin from July 2021 to June 2023. Data from 692 inpatients across various hospital departments were examined (409 for levofloxacin and 283 for ciprofloxacin). Statistical analysis was performed via IBM SPSS version 23.0 to summarize the demographic, clinical, and epidemiological data.

RESULTS

The sociodemographic profile revealed diverse age distributions, with 25.4% and 39% older than 50 years for ciprofloxacin and levofloxacin, respectively. Ciprofloxacin was predominantly used in the oncology department (28.2%), with surgical prophylaxis (22.6%) and febrile or afebrile neutropenia (21.1%) being the most common indications. Levofloxacin was predominantly used in the medical ward (45.7%), mainly for lower respiratory tract infection (58.8%) and prophylaxis for bone marrow transplantation (16.5%). Enterococcus and methicillin-resistant Staphylococcus aureus were the most commonly isolated pathogens, with 62.5% of the isolates demonstrating resistance to ciprofloxacin. Moreover, extended-spectrum beta-lactamase-producing Enterobacterales were the most common pathogen isolated, with 33.3% being resistant to levofloxacin. Statistical analysis revealed a significant association between the choice of antibiotic and the approach to therapy. Levofloxacin was significantly more likely than ciprofloxacin to be used as empiric therapy (p < 0.001), whereas ciprofloxacin was more likely to be used as targeted therapy (p < 0.001).

CONCLUSIONS

This study investigated prescribing practices and resistance to levofloxacin and ciprofloxacin in a large hospital in a developing country. According to the bacterial resistance profiles, we conclude that there is a need for hospital departments to exercise greater restraint on the use of these antibiotics. To this end, further studies addressing the clinical efficacy of fluoroquinolones against the current treatment guidelines to evaluate their appropriateness should be carried out.

摘要

背景

氟喹诺酮类药物是最常被开的抗生素。由于它们具有已知的推动抗菌药物耐药性的倾向,因此需要对其处方模式进行更严格的限制。本研究旨在描述氟喹诺酮类药物的处方临床实践、肾功能损害患者的剂量调整以及细菌耐药谱,最终为优化当地人群的抗生素处方实践提供循证建议。

方法

这是一项在巴勒斯坦纳贾赫国立大学医院进行的回顾性、横断面研究。数据来自 2021 年 7 月至 2023 年 6 月期间接受环丙沙星或左氧氟沙星治疗的住院患者。共检查了 692 名来自不同医院科室的住院患者的数据(左氧氟沙星 409 例,环丙沙星 283 例)。使用 IBM SPSS 版本 23.0 进行统计分析,以总结人口统计学、临床和流行病学数据。

结果

社会人口统计学特征显示出不同的年龄分布,环丙沙星和左氧氟沙星的年龄分别有 25.4%和 39%大于 50 岁。环丙沙星主要用于肿瘤科(28.2%),最常见的适应症是手术预防(22.6%)和发热或不发热性中性粒细胞减少症(21.1%)。左氧氟沙星主要用于内科病房(45.7%),主要用于下呼吸道感染(58.8%)和骨髓移植预防(16.5%)。肠球菌和耐甲氧西林金黄色葡萄球菌是最常见的分离病原体,62.5%的分离物对环丙沙星耐药。此外,产超广谱β-内酰胺酶的肠杆菌科是最常见的分离病原体,33.3%对左氧氟沙星耐药。统计分析显示,抗生素的选择与治疗方法之间存在显著关联。左氧氟沙星比环丙沙星更有可能被用作经验性治疗(p<0.001),而环丙沙星更有可能被用作靶向治疗(p<0.001)。

结论

本研究调查了在一个发展中国家的大型医院中左氧氟沙星和环丙沙星的处方实践和耐药情况。根据细菌耐药谱,我们得出结论,医院科室需要对这些抗生素的使用更加谨慎。为此,应进一步开展针对氟喹诺酮类药物针对当前治疗指南的临床疗效的研究,以评估其适宜性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bf9/11342551/043f091eb836/12879_2024_9749_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bf9/11342551/7dad4ce9d239/12879_2024_9749_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bf9/11342551/043f091eb836/12879_2024_9749_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bf9/11342551/7dad4ce9d239/12879_2024_9749_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bf9/11342551/043f091eb836/12879_2024_9749_Fig2_HTML.jpg

相似文献

1
Patterns of fluoroquinolone utilization and resistance in a tertiary care hospital: a retrospective cross-sectional analysis study from a developing country.氟喹诺酮类药物利用与耐药模式:来自发展中国家的三级医院回顾性横断面分析研究。
BMC Infect Dis. 2024 Aug 23;24(1):856. doi: 10.1186/s12879-024-09749-4.
2
Comparative activity of ciprofloxacin and levofloxacin against isolated uropathogens in Ghana: a pilot study.环丙沙星和左氧氟沙星对加纳分离出的尿路病原体的比较活性:一项初步研究。
Pan Afr Med J. 2018 Jul 5;30:194. doi: 10.11604/pamj.2018.30.194.15457. eCollection 2018.
3
Hospital-based ciprofloxacin use evaluation in Eastern Ethiopia: a retrospective assessment of clinical practice.基于医院的环丙沙星使用评估在东埃塞俄比亚:临床实践的回顾性评估。
Pan Afr Med J. 2021 Jan 19;38:62. doi: 10.11604/pamj.2021.38.62.21626. eCollection 2021.
4
Evaluating outcomes associated with revised fluoroquinolone breakpoints for Enterobacterales urinary tract infections: A retrospective cohort study.评估与肠杆菌科细菌尿路感染氟喹诺酮类药物修订断点相关的结局:一项回顾性队列研究。
Eur J Clin Microbiol Infect Dis. 2022 May;41(5):741-749. doi: 10.1007/s10096-022-04428-1. Epub 2022 Feb 28.
5
Moxifloxacin versus levofloxacin or ciprofloxacin prophylaxis in acute myeloid leukemia patients receiving chemotherapy.莫西沙星与左氧氟沙星或环丙沙星用于接受化疗的急性髓系白血病患者的预防治疗比较
Support Care Cancer. 2017 Dec;25(12):3715-3721. doi: 10.1007/s00520-017-3797-2. Epub 2017 Jun 28.
6
Fluoroquinolone resistance of Pseudomonas aeruginosa isolates causing nosocomial infection is correlated with levofloxacin but not ciprofloxacin use.铜绿假单胞菌引起医院感染的氟喹诺酮类耐药与左氧氟沙星而非环丙沙星的使用相关。
Int J Antimicrob Agents. 2010 Mar;35(3):261-4. doi: 10.1016/j.ijantimicag.2009.11.007. Epub 2009 Dec 31.
7
Ciprofloxacin and levofloxacin resistance among methicillin-sensitive Staphylococcus aureus isolates from keratitis and conjunctivitis.来自角膜炎和结膜炎的甲氧西林敏感金黄色葡萄球菌分离株对环丙沙星和左氧氟沙星的耐药性
Am J Ophthalmol. 2004 Mar;137(3):453-8. doi: 10.1016/j.ajo.2003.10.026.
8
Ciprofloxacin vs. levofloxacin for prophylaxis in recipients of hematopoietic stem cell transplantation.环丙沙星与左氧氟沙星用于造血干细胞移植受者的预防治疗比较
J Oncol Pharm Pract. 2019 Jun;25(4):884-890. doi: 10.1177/1078155218787286. Epub 2018 Jul 24.
9
Evaluation of Clostridium difficile-associated diarrhea with a drug formulary change in preferred fluoroquinolones.在首选氟喹诺酮类药物的药品处方集发生变化的情况下,对艰难梭菌相关性腹泻进行评估。
J Manag Care Pharm. 2008 Jan-Feb;14(1):34-40. doi: 10.18553/jmcp.2008.14.1.34.
10
Fluoroquinolone susceptibility in Mycobacterium tuberculosis after pre-diagnosis exposure to older- versus newer-generation fluoroquinolones.结核分枝杆菌在诊断前接触老一代与新一代氟喹诺酮类药物后的氟喹诺酮类药物敏感性。
Int J Antimicrob Agents. 2013 Sep;42(3):232-7. doi: 10.1016/j.ijantimicag.2013.04.027. Epub 2013 Jun 24.

引用本文的文献

1
The Rise, Fall, and Rethink of (Fluoro)quinolones: A Quick Rundown.(氟)喹诺酮类药物的兴衰与重新审视:简要概述
Pathogens. 2025 May 24;14(6):525. doi: 10.3390/pathogens14060525.

本文引用的文献

1
Antibiotic resistance profiles and associated factors of Pseudomonas Infections among patients admitted to large tertiary care hospital from a developing country.发展中国家大型三级护理医院住院患者铜绿假单胞菌感染的抗生素耐药谱及相关因素。
Antimicrob Resist Infect Control. 2023 Dec 20;12(1):149. doi: 10.1186/s13756-023-01355-4.
2
Fluoroquinolone Prophylaxis during Conventional Chemotherapy or Hematopoietic Stem Cell Transplantation for Acute Leukemia - Pros and Cons.氟喹诺酮类药物在急性白血病常规化疗或造血干细胞移植期间的预防作用——利弊。
Acta Haematol. 2024;147(2):186-197. doi: 10.1159/000535119. Epub 2023 Nov 21.
3
Fluoroquinolone prophylaxis in patients with neutropenia at high risk of serious infections: Exploring pros and cons.
氟喹诺酮类药物预防高危中性粒细胞减少症患者严重感染:探讨利弊。
Transpl Infect Dis. 2023 Nov;25 Suppl 1:e14152. doi: 10.1111/tid.14152. Epub 2023 Sep 25.
4
Antibiotic consumption and antimicrobial resistance in the SARS-CoV-2 pandemic: A single-center experience.2019冠状病毒病大流行期间的抗生素使用与抗菌药物耐药性:单中心经验
Front Pharmacol. 2023 Mar 15;14:1067973. doi: 10.3389/fphar.2023.1067973. eCollection 2023.
5
Trends in the hospital-sector consumption of the WHO AWaRe Reserve group antibiotics in EU/EEA countries and the United Kingdom, 2010 to 2018.2010 年至 2018 年欧盟/欧洲经济区国家和英国世卫组织 AWaRe 储备集团抗生素在医院部门的使用趋势。
Euro Surveill. 2022 Oct;27(41). doi: 10.2807/1560-7917.ES.2022.27.41.2101058.
6
Chemotherapy-induced neutropenia and emerging agents for prevention and treatment: A review.化疗诱导的中性粒细胞减少症及预防和治疗的新型药物:综述
Cancer Treat Rev. 2022 Sep;109:102427. doi: 10.1016/j.ctrv.2022.102427. Epub 2022 Jun 21.
7
Impact of the COVID-19 Pandemic on Inpatient Antibiotic Consumption in Switzerland.新冠疫情对瑞士住院患者抗生素使用的影响。
Antibiotics (Basel). 2022 Jun 11;11(6):792. doi: 10.3390/antibiotics11060792.
8
Chemotherapy-Induced Neutropenia and Febrile Neutropenia in the US: A Beast of Burden That Needs to Be Tamed?美国的化疗所致中性粒细胞减少症和发热性中性粒细胞减少症:一种需要驯服的负担?
Oncologist. 2022 Aug 5;27(8):625-636. doi: 10.1093/oncolo/oyac074.
9
Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis.2019 年全球细菌对抗菌药物耐药性的负担:系统分析。
Lancet. 2022 Feb 12;399(10325):629-655. doi: 10.1016/S0140-6736(21)02724-0. Epub 2022 Jan 19.
10
Fluoroquinolone antibiotics and adverse events.氟喹诺酮类抗生素与不良事件。
Aust Prescr. 2021 Oct;44(5):161-164. doi: 10.18773/austprescr.2021.035. Epub 2021 Oct 1.